The aldosterone receptor - New insights?

Expert Opinion on Investigational Drugs

Volumn 15, Issue 3, 2006, Pages 201-203

  Fuller, Peter ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Aldosterone; Aldosterone receptor; Mineralocorticoid; Mineralocorticoid receptor; SMRM

Indexed keywords

ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR; ANDROGEN RECEPTOR; EPLERENONE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; MINERALOCORTICOID ANTAGONIST; MINERALOCORTICOID RECEPTOR; POTASSIUM; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SPIRONOLACTONE; STEROID RECEPTOR; TAMOXIFEN;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CRYSTALLIZATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; EDITORIAL; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; MORTALITY; PATHOPHYSIOLOGY; PROTEIN FUNCTION; RECEPTOR BLOCKING; STRUCTURE ANALYSIS; TISSUE SPECIFICITY;

ALDOSTERONE ANTAGONISTS; CARDIOVASCULAR DISEASES; HUMANS; RECEPTORS, ALDOSTERONE;

EID: 33644781442     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.15.3.201     Document Type: Editorial

References (11)

1. FULLER PJ, YOUNG MJ: Mechanisms of mineralocorticoid action. Hypertension (2005) 46:1227-1235
2. FUNDER JW. Is aldosterone bad for the heart? Trends Endocrinol. Metab. (2004) 15:139-42.
3. JUURLINK DN, MAMDANI MM, LEE DS et al.: Rates of hyperkalemia after publication of the Randomized Aldacrone Evaluation Study. N. Engl. J. Med. (2004) 351:543-551
4. LEVY DG, ROCHA R, FUNDER JW: Distinguishing the antihypertensive and electrolyte effects of eplerenone. J. Clin. Endocrinoll. Metab. (2004) 89:2736-2740.
5. BOHL CF, MILLER DD, CHEN J, BELL CF, DALTON JT: Structural basis for accommodation of nonsteroidal ligands in the androgen receptor. J. Biol. Chem. (2005) 280:37747-37754.
6. MINER JN, HONG MH, NEGRO-VILAR A: New and improved glucocorticoid receptor ligands. Expert Opin. Investig. Drugs (2005) 14:1527-1545.
7. GRONEMEYER H, GUSTAFSSON JÅ, LAUDET V: Principles for modulation of the nuclear receptor superfamily. Nat. Rev. (2004) 3:950-964
8. KAUPP B, JAKOB C, FARNEGARDH M et al.: The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain. J. Biol. Chem. (2003) 278:22748-22754.
9. FAGART J, HUYET J, PINON GM et al.: Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat. Struct. Mol. Biol. (2005) 12:554-555.
10. LI Y, SUINO K, DAUGHERTY J, XU HE: Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol. Cell (2005) 19:367-380.
11. BLEDSOE RK MADAUSS KP, HOLT JA et al.: A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J. Biol. Chem. (2005) 280:31283-31293.